239 related articles for article (PubMed ID: 35986566)
1. Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice.
Reifsnyder PC; Flurkey K; Doty R; Calcutt NA; Koza RA; Harrison DE
Aging Cell; 2022 Sep; 21(9):e13666. PubMed ID: 35986566
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.
Reifsnyder PC; Flurkey K; Te A; Harrison DE
Aging (Albany NY); 2016 Nov; 8(11):3120-3130. PubMed ID: 27922820
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.
Reifsnyder PC; Doty R; Harrison DE
PLoS One; 2014; 9(12):e114324. PubMed ID: 25473963
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.
Zhou W; Ye S
Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010
[TBL] [Abstract][Full Text] [Related]
5. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats.
Nistala R; Raja A; Pulakat L
Can J Physiol Pharmacol; 2017 Mar; 95(3):281-287. PubMed ID: 28177677
[TBL] [Abstract][Full Text] [Related]
7. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
8. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
Rai RC; Bagul PK; Banerjee SK
Life Sci; 2020 Jul; 253():117727. PubMed ID: 32371063
[TBL] [Abstract][Full Text] [Related]
10. Metformin preconditioned adipose derived mesenchymal stem cells is a better option for the reversal of diabetes upon transplantation.
Shree N; Bhonde RR
Biomed Pharmacother; 2016 Dec; 84():1662-1667. PubMed ID: 27842906
[TBL] [Abstract][Full Text] [Related]
11. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice.
Fujita H; Fujishima H; Koshimura J; Hosoba M; Yoshioka N; Shimotomai T; Morii T; Narita T; Kakei M; Ito S
Endocr J; 2005 Aug; 52(4):427-33. PubMed ID: 16127210
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
13. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
Després JP
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.
Tahara A; Takasu T
Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626
[No Abstract] [Full Text] [Related]
15. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
17. Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.
Tajima A; Hirata T; Taniguchi K; Kondo Y; Kato S; Saito-Hori M; Ishimoto T; Yamamoto K
Life Sci; 2011 Oct; 89(17-18):662-70. PubMed ID: 21872612
[TBL] [Abstract][Full Text] [Related]
18. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
[TBL] [Abstract][Full Text] [Related]
19. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
[TBL] [Abstract][Full Text] [Related]
20. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
